Pharmacokinetics and Pharmacodynamics: Optimal Antimicrobial Therapy in the Intensive Care Unit

被引：25

作者：

Lodise, Thomas P. ^{[1
,2
]}

Drusano, G. L. ^{[1
]}

机构：

[1] Ordway Res Inst, Albany, NY 12208 USA

[2] Albany Coll Pharm & Hlth Sci, Albany, NY USA

来源：

CRITICAL CARE CLINICS | 2011年 / 27卷 / 01期

关键词：

Antimicrobial therapy; Intensive care unit; Pharmacokinetics; Pharmacodynamics; VANCOMYCIN-INDUCED NEPHROTOXICITY; BLOOD-STREAM INFECTIONS; PSEUDOMONAS-AERUGINOSA; PIPERACILLIN-TAZOBACTAM; PROTEIN-BINDING; RESISTANCE; AMINOGLYCOSIDE; SELECTION; OUTCOMES; MODEL;

D O I：

10.1016/j.ccc.2010.11.003

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

This article reviews the principles of antimicrobial pharmacokinetics and pharmacodynamics in the context of the ICU for the most commonly used antibiotics. For therapy to truly be efficacious, the regimen must be effective against the organism, but not harmful to the patient. We review how optimization of chemotherapy requires a careful balancing of efficacy against toxicity when selecting dose and dose schedules. In addition, we discuss the importance of considering concentrations at the site of infection and how dose optimization can help suppress resistance emergence and preserve our antimicrobial armamentarium for the future. Finally, we examine combination chemotherapy and strategies for optimizing the administration of multiple agents.

引用

页码：1 / +

页数：19

共 55 条

[1]

[Anonymous], 2010, CLSI Document M100-S20

[2] EFFECTS OF VANCOMYCIN ON RENAL-FUNCTION IN RATS [J].

ARONOFF, GR ;

SLOAN, RS ;

DINWIDDIE, CB ;

GLANT, MD ;

FINEBERG, NS ;

LUFT, FC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (02) :306-308

[3] Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections [J].

Berthoin, Karine ;

Ampe, Els ;

Tulkens, Paul M. ;

Carryn, Stephane .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (06) :555-560

[4] Relevance of plasma protein binding to antiviral activity and clinical efficacy of inhibitors of human immunodeficiency virus protease [J].

Bilello, JA ;

Drusano, GL .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) :1524-1525

[5] Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity [J].

Celik, I ;

Cihangiroglu, M ;

Ilhan, N ;

Akpolat, N ;

Akbulut, HH .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 97 (05) :325-332

[6] Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model [J].

Cetin, Hasan ;

Olgar, Seref ;

Oktem, Faruk ;

Ciris, Metin ;

Uz, Efkan ;

Aslan, Cagatay ;

Ozguner, Fehmi .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (11) :1181-1185

[7]

Clinical and Laboratory Standards Institute, 2006, M2M9 NCCLS CLSI

[8] Pharmacokinetics and pharmacodynamics of antibiotics in otitis media [J].

Craig, WA ;

Andes, D .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (03) :255-259

[9] INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS [J].

CRAIG, WA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) :89-96

[10] Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].

Craig, WA .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10

← 1 2 3 4 5 6 →